Combined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii

LUIS MARTINEZ MARTINEZ2026-01-292026-01-29201910.3390/microorganisms71105562-s2.0-85074975093https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31041MicrobiologyMicrobiology (medical)VirologyCombined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumanniiresearch article